ARTICLE-9: Exemption from the general obligation to register for product and process orientated research and development (PPORD) [
go to this ARTICLE]
ARTICLE-15: Substances in plant protection and biocidal products [
go to this ARTICLE]
ARTICLE-28: Duty to pre-register for phase-in substances [
go to this ARTICLE]
ARTICLE-31: Requirements for Safety Data Sheets [
go to this ARTICLE]
ARTICLE-41: Compliance check of registrations [
go to this ARTICLE]
ARTICLE-43: Procedure and time periods for examination of testing proposals [
go to this ARTICLE]
ARTICLE-59: Identification of substances referred to in Article 57 [
go to this ARTICLE]
ARTICLE-69: Preparation of a proposal [
go to this ARTICLE]
... 4. If a
Member State considers that the
manufacture, placing on the
market or use of a
substance on its own, in a
preparation or in an
article poses a
risk to
human health or the
environment that is not adequately controlled and needs to be addressed it shall notify the
Agency that it
proposes to prepare a
dossier which conforms to the
requirements of the
relevant sections of Annex XV. If the
substance is not on the
list maintained by the
Agency referred to in paragraph 5 of this
Article, the
Member State shall prepare a
dossier which conforms to the
requirements of Annex XV within 12
months of the
notification to the
Agency. If this
dossier demonstrates that
action on a
Community-
wide basis is necessary, beyond any
measures already in
place, the
Member State shall submit it to the
Agency in the format outlined in Annex XV, in
order to initiate the
restrictions process. The
Agency or
Member States shall refer to any
dossier,
chemical safety report or
risk assessment submitted to the
Agency or
Member State under this
Regulation. The
Agency or
Member States shall also refer to any
relevant risk assessment submitted for the
purposes of other
Community Regulations or Directives. To this end other
bodies, such as
agencies,
established under
Community law and carrying out a similar task shall provide
information to the
Agency or
Member State concerned on
request. The
Committee for
Risk Assessment and the
Committee for
Socio-economic Analysis shall check whether the
dossier submitted conforms to the
requirements of Annex XV. Within 30
days of
receipt, the respective
Committee shall inform the
Agency or the
Member State suggesting
restrictions, as to whether the
dossier conforms. If the
dossier does not conform, the
reasons shall be given to the
Agency or the
Member State in
writing within 45
days of
receipt. The
Agency or the
Member State shall bring the
dossier into
conformity within 60
days of the
date of receipt of the
reasons from the
Committees, otherwise the
procedure under this
Chapter shall be terminated. The
Agency shall
publish without
delay the
intention of the
Commission or of a
Member State to instigate a
restriction procedure for a
substance and shall inform those who submitted a
registration for that
substance. ...
ARTICLE-84: Appointment of the Executive Director [
go to this ARTICLE]
ARTICLE-85: Establishment of the Committees [
go to this ARTICLE]
ARTICLE-87: Rapporteurs of Committees and use of experts [
go to this ARTICLE]
ARTICLE-89: Establishment of the Board of Appeal [
go to this ARTICLE]
ARTICLE-90: Members of the Board of Appeal [
go to this ARTICLE]
ARTICLE-96: The budget of the Agency [
go to this ARTICLE]